Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 291.50
Bid: 293.50
Ask: 295.00
Change: -10.50 (-3.48%)
Spread: 1.50 (0.511%)
Open: 300.00
High: 304.00
Low: 291.50
Prev. Close: 302.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Deputy Chair and Chair-elect

30 Mar 2020 07:00

RNS Number : 9553H
Synthomer PLC
30 March 2020
 

Synthomer plc

30th March 2020

 

Synthomer plc ('Synthomer')

 

Caroline Johnstone appointed Deputy Chair and Chair-elect of Synthomer

 

The Board of Directors ('the Board') of Synthomer ('the Company') announces today that Neil Johnson will step down as Chairman of the Company by the end of the year. Neil has served as Chairman for eight years since his appointment to the Board in September 2011 as a non-executive director. At the 2020 AGM Neil will seek re-election as a Director in order to serve as Chairman until the end of the year.

 

Following an external and internal process, the Board is pleased to announce that Caroline Johnstone will be appointed Chair upon Neil's departure. She will take up the position of Deputy Chair with immediate effect. Caroline joined the Board of Synthomer as a non-executive director in 2015 and is currently Chair of the Audit Committee and a member of the Nomination and Remuneration Committees.

 

Caroline has nearly 40 years' experience of working with large global organisations on turnaround, culture change, delivering value from mergers and acquisitions and cost optimisation programmes. She was a partner and sat on the board of the Assurance practice of PricewaterhouseCoopers (PwC) with responsibility for all people matters. Caroline is a chartered accountant and a member of the Institute of Chartered Accountants of Scotland. She is a non-executive director of Spirax Sarco Engineering plc and two private companies and by the end of 2020 intends to have two non-executive roles in addition to Synthomer plc.

 

Neil Johnson, Chairman of Synthomer, commented:

 

"It has been a pleasure serving on the Board of Synthomer since 2011, during which time we have made significant progress in establishing the Company as a leading, global, differentiated chemicals business. Despite the challenges of the current economic environment, the recent completion of a material capital investment programme and the benefits that will come from the acquisition of OMNOVA give me confidence that the Company is well-placed for the future. I am delighted that I will be succeeded as Chair by Caroline Johnstone, who has made a significant contribution to the Company during her time on the Board, and I look forward to continuing to serve Synthomer until I hand over by the end of the year.." 

 

Enquiries:

 

Synthomer plc

Tel: + 44 7764 859147

Calum MacLean, Chief Executive Officer

 

Stephen Bennett, Chief Financial Officer

 

Tim Hughes, President, Corporate Development

 

 

 

Teneo

Tel: + 44 7703 330269

Charles Armitstead / Matt Denham

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDXLXDDGGC
Date   Source Headline
30th Jul 20197:00 amRNSResults of Rights Issue
26th Jul 20192:48 pmRNSDirector/PDMR Shareholding
26th Jul 20192:46 pmRNSDirector/PDMR Shareholding
24th Jul 20194:34 pmRNSDirector Declaration
15th Jul 20197:00 amRNSAdmission of Nil Paid Rights
10th Jul 20191:49 pmRNSPublication of Circular and Prospectus
10th Jul 20191:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAcquisition
2nd Jul 20193:56 pmRNSDirector Declaration
13th Jun 201911:18 amRNSDirector Declaration
25th Apr 20194:45 pmRNSResult of AGM
25th Apr 20197:00 amRNSQ1 Trading Update
10th Apr 20194:51 pmRNSDirector/PDMR Shareholding
10th Apr 20194:50 pmRNSDirector/PDMR Shareholding
10th Apr 20194:43 pmRNSDirector/PDMR Shareholding
10th Apr 20194:41 pmRNSDirector/PDMR Shareholding
28th Mar 20193:51 pmRNSDirector/PDMR Shareholding
28th Mar 20193:50 pmRNSDirector/PDMR Shareholding
25th Mar 20193:15 pmRNSAnnual Financial Report
21st Mar 20193:39 pmRNSDirector Declaration
18th Mar 201910:02 amRNSDirector/PDMR Shareholding
12th Mar 201911:25 amRNSDirector/PDMR Shareholding
12th Mar 201911:23 amRNSDirector/PDMR Shareholding
5th Mar 20194:09 pmRNSDirector/PDMR Shareholding
4th Mar 20197:00 amRNSResults for the year ended 31 December 2018
1st Mar 20193:26 pmRNSDirector Declaration
3rd Dec 201810:54 amRNSHolding(s) in Company
9th Nov 201811:36 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSQ3 Trading update
17th Oct 20189:29 amRNSDirector Declaration
21st Sep 20189:17 amRNSDirectorate Change
6th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20186:25 pmRNSDirector/PDMR Shareholding
10th Jul 20189:47 amRNSHolding(s) in Company
4th Jul 201811:45 amRNSHolding(s) in Company
4th Jul 201811:44 amRNSHolding(s) in Company
4th Jul 201811:43 amRNSHolding(s) in Company
28th Jun 20183:12 pmRNSUpdate on Proposed Offering
25th Jun 20187:19 amRNSPROPOSED OFFERING OF EUR300M BOND & REFINANCING
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM
3rd May 20181:38 pmRNSHolding(s) in Company
2nd May 20184:29 pmRNSDirector/PDMR Shareholding
26th Apr 20182:23 pmRNSResult of AGM
26th Apr 20187:00 amRNSQ1 Trading update
9th Apr 20184:54 pmRNSDirector Declaration
27th Mar 20181:03 pmRNSDirector/PDMR Shareholding
27th Mar 20181:01 pmRNSDirector/PDMR Shareholding
26th Mar 20184:55 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.